ALK7 obesity breakthrough featured in Science-Business eXchange

Article in Science-Business eXchange (SciBX) features ALK7 breakthrough discovery from Carlos Ibanez lab. SciBX’s Chris Cain quizzes Carlos Ibanez on the latest findings from the team, with comments from Alan Saltiel (University of Michigan) and John Knopf (CEO, Acceleron Pharma Inc.).
SciBX (2014) 7(37); doi:10.1038/scibx.2014.1090
Click on thumbnail to display PDF